The Pioneer in Single-Test Chemiluminescence - MQ60 Series Single-Test Chemiluminescence Detection Reagents

The chemiluminescence detection reagent market primarily features two packaging formats: single-test chemiluminescence (designed for rapid detection of one item per package, ideal for small instruments) and tube-based chemiluminescence (one bottle can support tests for up to 100 samples, designed for large instruments). Both formats have unique advantages. Tube-based chemiluminescence, with its larger packaging, is well-suited for high-volume hospitals, as it is unaffected by reagent stability after opening. However, for smaller healthcare facilities with lower patient volumes, tube-based chemiluminescence packaging becomes impractical. In contrast, single-test chemiluminescence offers flexibility and convenience with one test per cartridge. Notably, single-test chemiluminescence instruments are designed without liquid pathway systems, resulting in low failure rates and offering simple and convenient operation. Practical applications globally demonstrate that single-test chemiluminescence instruments and their corresponding reagents are well-suited for widespread implementation as diagnostic solutions globally.

Hotgen Biotech MQ60 Single-Test Chemiluminescence Detection Reagents

Hotgen Biotech introduces the MQ60 series single-test chemiluminescence immunoassay analyzers (MQ60 Smart, MQ60 ProB, MQ60 Plus) to meet the needs of global healthcare providers, which support over 110 certified tests, including inflammatory markers, cardiac markers, thyroid function, sex hormones, tumor markers, hypertension, diabetes, and anemia panels, catering to hospitals of various sizes.

Single-Test Chemiluminescence Detection Reagents Enhance Primary Care Capabilities and Reduce Reagent Waste

Single-test chemiluminescence combines the precision of chemiluminescence with the flexibility of POCT (Point-of-Care Testing). It is simple to use, offers rapid results, and supports testing as needed. A compact chemiluminescence analyzer can perform multiple tests, including tumor markers that were previously challenging due to reagent waste concerns.

No Consumables, No Hidden Costs, No Shelf-Life Restrictions After Opening

Hotgen Biotech's single-test chemiluminescence platform eliminates internal fluid pathways, with all reaction and washing steps performed within a single cartridge. This design ensures zero reagent waste while offering compact size, the ability to test single or multiple items, no consumable requirements, low failure rates, and freedom from shelf-life limitations after opening.

Accurate Results with Quality Control

Chemiluminescence delivers high sensitivity and accuracy, meeting the demand for high-quality results in primary care. Each single-test chemiluminescence reagent includes corresponding quality control materials, addressing the lack of or inconvenience of quality control in traditional POCT platforms.

Whole Blood Testing Capability

Single-test chemiluminescence supports numerous tests suited for primary care, such as inflammation, myocardial, and embolism emergency tests, with the ability to use whole blood for simple operation.

Cost Advantage with Insurance Coverage, Ideal for Primary Care

Amid increasing regulation of healthcare costs and reimbursement rates, chemiluminescence testing generally commands higher reimbursement rates than other methodologies, offering a clear financial advantage for healthcare providers.

Comprehensive Test Menu for Primary Care Needs

The MQ60 series single-test chemiluminescence reagents support over 110 tests, including inflammation, cardiac markers, embolism, thyroid function, sex hormones, diabetes, hypertension, bone metabolism, tumor markers, kidney injury, hepatitis, and liver cancer markers. These reagents are packaged for single use, support whole blood testing, require no consumables, incur no hidden costs, have no shelf-life restrictions after opening, and include quality control for reliable results.